Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by pmartino
Group name EquipePM
Item Type Journal Article
Title Fc-engineered monoclonal antibodies to reduce off-target liver uptake
Creator Mangeat et al.
Author Tristan Mangeat
Author Matthieu Gracia
Author Alexandre Pichard
Author Sophie Poty
Author Pierre Martineau
Author Bruno Robert
Author Emmanuel Deshayes
Abstract BACKGROUND: Radiolabeled-antibodies usually display non-specific liver accumulation that may impair image analysis and antibody biodistribution. Here, we investigated whether Fc silencing influenced antibody biodistribution. We compared recombinant 89Zr-labeled antibodies (human IgG1 against different targets) with wild-type Fc and with mutated Fc (LALAPG triple mutation to prevent binding to Fc gamma receptors; Fc?R). After antibody injection in mice harboring xenografts of different tumor cell lines or of immortalized human myoblasts, we analyzed antibody biodistribution by PET-CT and conventional biodistribution analysis. RESULTS: Accumulation in liver was strongly reduced and tumor-specific targeting was increased for the antibodies with mutated Fc compared with wild-type Fc. CONCLUSION: Antibodies with reduced binding to Fc?R display lower liver accumulation and better tumor-to-liver ratios. These findings need to be taken into account to improve antibody-based theragnostic approaches.
Publication EJNMMI research
Volume 13
Issue 1
Pages 81
Date 2023-09-11
Journal Abbr EJNMMI Res
Language eng
DOI 10.1186/s13550-023-01030-0
ISSN 2191-219X
Library Catalog PubMed
Extra PMID: 37697076 PMCID: PMC10495296
Tags bnif, Fc, Fc gamma receptor, first-last-corresponding, ipam, LALAPG mutation, ligue, mabimprove, Off-target, original, PET-CT, ram, siric, top
Date Added 2023/11/03 - 09:56:41
Date Modified 2023/11/20 - 14:54:54
Notes and Attachments Full Text (Attachment)
PubMed entry (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés